On November 5, Palantir fell 3.01% in Pre-Market Trading to $166.57/share, with turnover of $41.63 million.
The move came even as Truist raised its price target to $250 and Barclays had earlier lifted its target to $273, with the stock still facing lingering post-earnings pressure after a strong quarterly report failed to clear elevated investor expectations.
Palantir recently reported Q3 revenue of $2.313 billion and adjusted EPS of $0.44, both above consensus, while guiding Q4 revenue to $2.649 billion-$2.653 billion and raising full-year revenue guidance to $8.530 billion-$8.534 billion. However, order-related indicators remained a point of concern, with remaining performance obligations flat sequentially, helping explain why the shares continued to weaken despite favorable analyst target revisions and bullish options activity including a large December 2026 $140 put sale and call buying.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments